The average giant dog lives 8.9 years
Doges Editorial · 2026-06-28 · 6 min read
A new UK study of 28,000 giant breed dogs finds they die more than three years before the average dog, and cancer is usually why. The findings reshape what owners of Great Danes, Irish wolfhounds, and Saint Bernards should expect.
If you share your home with a Great Dane, an Irish wolfhound, or a Saint Bernard, you have probably already encountered the awkward math of giant dog ownership: the bills are larger, the food bags heavier, the veterinary tables barely wide enough. What the research has been slower to confirm is the one calculation that matters most — how long you actually get.
A study published on June 26, 2026, by the Royal Veterinary College's VetCompass Programme has put a number on it. It is 8.9 years. That is the average lifespan of a giant breed dog in England — more than three years shorter than the average lifespan recorded across all dogs in the same VetCompass dataset. For the Tibetan Mastiff, the number drops further still: 4.8 years on average.
The largest study of its kind
The RVC team analyzed anonymized veterinary records from 2.25 million dogs attending UK primary-care practices during 2019. From that population, they identified 28,345 giant dogs — defined as breeds with an average body weight above 45 kilograms, compared to the 14.3-kilogram average for all purebred dogs in the UK. They then manually reviewed clinical records from a random sample of more than 4,300 of those dogs to assess the most common health disorders and causes of death.
Twenty-nine breeds qualify as giant under this definition: among them, the Irish wolfhound (64 kilograms), the Saint Bernard (65.1 kilograms), and the Great Dane (60.5 kilograms). The three most common giant breeds seen at UK practices, perhaps unexpectedly, were not these famous names but the Dogue de Bordeaux, the Alaskan Malamute, and the Akita.
These were not dogs who existed only in theory. They were dogs brought into clinics by owners managing real health problems, at an age when the calendar becomes something you watch.
8.9 years in context
The three-year gap between giant breeds and the general dog population is not a rounding error. For a dog that might otherwise live to twelve or thirteen, three years is a quarter of a lifetime. It is the difference between being present for your child's middle school years and not being there for the first year of high school. That's the frame in which this number lives for the people who love these dogs.
The study found that female giant dogs outlive males by 0.8 years on average — 9.3 years versus 8.5. This aligns with patterns seen across many mammalian species, including humans, where females tend to outlive males. It's a small gap in absolute terms, but not insignificant when you're counting years at the end.
The researchers note that what drives this pattern is well-established in comparative biology: more rapid growth leads to more rapid aging. Giant dogs reach full body size within roughly eighteen months — a pace that compresses development in ways that appear to accelerate the cellular wear of aging. A Great Dane does not live a small dog's life on a faster clock. It lives a fundamentally different kind of life, shaped by a body that science is only now beginning to map in detail.
That pattern has a name at the molecular level: IGF-1. Large and giant breeds are selectively bred to grow quickly, and that rapid growth leaves them with chronically elevated levels of insulin-like growth factor 1, a hormone that drives cellular proliferation. While IGF-1 is necessary for a puppy's development, research connecting serum IGF-1 to adult body weight across dozens of breeds has shown a consistent pattern: higher adult body weight correlates with higher circulating IGF-1, and higher IGF-1 in adulthood correlates with shorter lifespan. The same hormonal axis that builds a 65-kilogram Saint Bernard in eighteen months appears to accelerate cellular senescence in the years that follow. Giant dogs don't simply age faster — their cells are operating under a different biological regime from the start. (Greer et al., 2011: https://pmc.ncbi.nlm.nih.gov/articles/PMC3168604)
Humanity has reshaped the domestic dog into the most physically diverse mammalian species on earth to create over 1,200 distinct dog breeds. Among these, the giant dog breeds can offer wonderful companionship for humans, but our findings suggest that the lifespan and welfare costs for these dogs, linked to their extreme body size, are substantial.
— Professor Dan O'Neill, Professor of Companion Animal Epidemiology at the RVC and lead author
What fills those years
The lifespan finding is the headline, but the disorder data tells a more textured story. Almost three-quarters of giant dogs — 73.8 percent — had at least one disorder recorded in a single year, compared with 65.8 percent across all dog breeds. They are getting sick more often, and they are getting sick from a wider variety of causes.
The most common specific diagnoses were ear infections (8.2 percent of giant dogs in a given year), overweight or obesity (8.0 percent), and aggression (5.6 percent). That aggression figure is striking: it is more than double the 2.2 percent rate recorded across all dog breeds in VetCompass. Giant breeds were historically developed as guarders and herders — selecting for size and protectiveness over many generations. The behavioral legacy of that selection is still present in the population.
The broader categories tell a similar story: skin disorders, musculoskeletal disease, and ear disease were the most common disorder groups. For owners, many of these translate into conditions they already sense — the stiffness in a five-year-old Dane's back legs during cold mornings, the recurring ear infections that need monthly management, the watchfulness around unfamiliar dogs. The study names what owners have been quietly managing for years.
Cancer, and what comes after
Cancer was identified as the leading cause of death in giant dogs. A companion VetCompass study published in 2023, examining osteosarcoma risk across 905,552 UK dogs, put specific odds on the disparity: Scottish Deerhounds were 118 times more likely to develop osteosarcoma than crossbreeds; Leonbergers 56 times; Great Danes 34 times; Rottweilers 27 times. Among Irish wolfhounds in a Swedish cohort, 12 percent had been diagnosed with the disease by age ten. Hemangiosarcoma — a cancer of blood vessels that often spreads before symptoms are visible — is estimated to affect more than 50,000 companion dogs in the United States annually, with median survival of five to seven months even after surgery and chemotherapy. These are not abstractions: they are the specific cancers that most commonly end giant dogs' lives, often suddenly, often earlier than owners expect. (VetCompass osteosarcoma study, 2023: https://link.springer.com/article/10.1186/s40575-023-00131-2; University of Minnesota Modiano Lab: https://vetmed.umn.edu/modiano-lab/cancer-center/hemangiosarcoma-detailed-article)
Cancer deaths in giant breeds often come suddenly. The dog that seems fine at a summer check-up may be gone by autumn. Owners of giant breeds frequently describe this compressed timeline — a shorter window of gradual decline, a more abrupt ending. The study doesn't change this reality, but it names it plainly, which matters for preparation and for veterinary planning.
What the researchers want owners to know
The study was not designed to discourage ownership of giant breeds. Professor O'Neill and his co-authors are explicit about this: these dogs offer real companionship, and many owners find the experience of living with a large dog irreplaceable in specific ways. The point of the research is to make that experience more informed — to close the gap between what people expect and what the veterinary data shows.
Among the paper's suggestions: moving toward more moderate body sizes within giant breeds may improve both quality and length of life while preserving what owners value about these dogs. There is also practical advice embedded in the findings — female dogs appear to live longer; aggression in giant breeds warrants serious behavioral assessment before acquisition; early relationships with veterinarians familiar with giant breed health can improve disease detection before it becomes crisis.
One counterintuitive finding from adjacent research is worth noting. Giant breeds rarely live long enough to develop canine cognitive dysfunction — the dementia-like decline that affects many senior dogs in their final years. Cognitive scientist Evan MacLean at the University of Arizona has found that cognitive decline in dogs tracks with species-equivalent age rather than calendar years: 'Big dogs may just die before they acquire any kind of cognitive dysfunction,' he has noted. For an eight-year-old Great Dane, the cognitive baseline tends to remain intact. It's a trade-off that runs deep — a shorter, sharper life, without the slow fade that visits smaller dogs who live long enough to reach it. (MacLean, University of Arizona: https://news.arizona.edu/news/new-u-study-will-investigate-growth-hormones-and-cognitive-aging-dogs)
The relatively short lives of giant dogs compared to the wider dog population should prompt wider discussion on the welfare limits of selective breeding towards extreme giantism. To protect these cherished breeds and make them sustainable for the future, moving towards more moderate body sizes within these breeds may help to improve both the quality and length of life for these dogs.
— Professor Dan O'Neill, Royal Veterinary College
The dog at the end of the lead
BSAVA welcomes this research, which adds to the growing evidence base needed to improve canine health and welfare. The veterinary profession remains concerned about the health consequences associated with extreme conformations and is committed to supporting reforms through research, education and evidence-based breeding practices.
— Dr Julian Hoad, BSAVA Senior Vice President
For owners of giant breeds, the study lands in a particular way. Anyone who has walked a Great Dane already knows something about shortened time — not from a research paper, but from the way experienced owners talk, from the veterinarian who mentions it gently at the first check-up, from the actuarial weight of the animal's size. What the RVC has now done is quantify it.
Eight-point-nine years is not a sentence. It is a constraint, and within that constraint is everything — the slow winter morning walks when a 65-kilogram dog sets the pace, the peculiar warmth of a body that large resting against you, the thousand small daily things you will eventually look back on. Knowing the number doesn't make those things shorter. It makes them clearer.